Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Cantor Fitzgerald
Harvard Business School
Fish and Richardson
Federal Trade Commission

Generated: October 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019123

« Back to Dashboard
NDA 019123 describes KLOR-CON, which is a drug marketed by Upsher-smith Labs and is included in three NDAs. It is available from seventeen suppliers. Additional details are available on the KLOR-CON profile page.

The generic ingredient in KLOR-CON is potassium chloride. There are two hundred and thirty-two drug master file entries for this compound. Seventy-three suppliers are listed for this compound. Additional details are available on the potassium chloride profile page.

Summary for NDA: 019123

Therapeutic Class:Therapeutic Nutrients/Minerals/Electrolytes
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 019123

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
potassium chloride
TABLET, EXTENDED RELEASE;ORAL 019123 NDA Upsher-Smith Laboratories, Inc. 0245-0040 0245-0040-00 1 BAG in 1 BOX (0245-0040-00) > 10000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BAG
potassium chloride
TABLET, EXTENDED RELEASE;ORAL 019123 NDA Upsher-Smith Laboratories, Inc. 0245-0040 0245-0040-01 10 BLISTER PACK in 1 CARTON (0245-0040-01) > 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (0245-0040-89)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrength8MEQ
Approval Date:Apr 17, 1986TE:AB2RLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrength10MEQ
Approval Date:Apr 17, 1986TE:AB2RLD:Yes

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Cantor Fitzgerald
Federal Trade Commission
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus